MedPath

User Performance and System Accuracy Evaluations Using Glucose Adjustment

Not Applicable
Completed
Conditions
Type 1 Diabetes Mellitus
Interventions
Device: Blood Glucose Monitoring Systems.
Registration Number
NCT02374879
Lead Sponsor
LifeScan
Brief Summary

This is an open-label, non-randomised pilot study, to evaluate user performance and system accuracy in blood Glucose monitoring system with glucose adjustment. Twelve male and female volunteers aged 18-45, with a documented diagnosis of Type I diabetes for at least 12 will be enrolled in this study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Blood Glucose monitoring System (BGMS)Blood Glucose Monitoring Systems.Intervention: Blood Glucose monitoring System (BGMS) Results obtained from the BGMS for UP and SA are compared to a reference instrument (YSI)
Primary Outcome Measures
NameTimeMethod
User Performance (UP) evaluation.Up to 6 hours

UP evaluation of blood glucose monitoring systems compared to a reference instrument. Samples collected by subject and HCP

System Accuracy (SA) evaluationUp to 6 hours

UP evaluation of blood glucose monitoring systems compared to a reference instrument. Samples collected by HCP only.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

BioKinetic Europe Ltd

🇬🇧

Belfast, Antrim, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath